Obesity newcomer Kalohexis makes confidential IPO bid 3 months after spinoff at Tristan Manalac

Location: Unknown.

Employment type: full-time.

Key skills: GLP.

Kalohexis is working on peptide therapies, including one for obesity that could offer an alternative approach to the GLP-1s that currently dominate the weight loss space.